Cannasoul Analytics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Cannasoul Analytics General Information
Description
Operator of a drug discovery company intended to develop botanical medicine and therapeutics derived from natural compounds. The company offers cannabis molecular analysis, clinical and pre-clinical trials, and research and development (R&D) and engages in the screening of cannabis and psilocybin extracts, isolated cannabinoids, and novel molecules on various cell line models, enabling researchers to bridge the gap between botanical medicine and the pharmaceutical industry.
Contact Information
Website
www.cannasoul.co.ilCorporate Office
- PO Box 3150
- 5 Tarshish Street
- Caesarea 3079822
- Israel
Corporate Office
- PO Box 3150
- 5 Tarshish Street
- Caesarea 3079822
- Israel
Cannasoul Analytics Timeline
Cannasoul Analytics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 03-Nov-2025 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 02-Nov-2023 | Completed | Generating Revenue | |||
| 1. Joint Venture | 23-Jan-2018 | Completed | Generating Revenue |
Cannasoul Analytics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cannasoul Analytics Patents
Cannasoul Analytics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4547633-A1 | Cannabinoid derivatives and compositions comprising same | Pending | 29-Jun-2022 | ||
| EP-4547633-A4 | Cannabinoid derivatives and compositions comprising same | Pending | 29-Jun-2022 | ||
| US-20250387417-A1 | Cannabinoid derivatives and compositions comprising same | Pending | 29-Jun-2022 | ||
| WO-2024003906-A1 | Cannabinoid derivatives and compositions comprising same | Inactive | 29-Jun-2022 | ||
| US-20250236578-A1 | Novel cannabinoid derivatives | Pending | 09-Feb-2022 | C07C39/23 |
Cannasoul Analytics Signals
Cannasoul Analytics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| InterCure | Corporation | Minority | ||
| TAO Synergies | Corporation | Minority |
Cannasoul Analytics FAQs
-
When was Cannasoul Analytics founded?
Cannasoul Analytics was founded in 2018.
-
Where is Cannasoul Analytics headquartered?
Cannasoul Analytics is headquartered in Caesarea, Israel.
-
What is the size of Cannasoul Analytics?
Cannasoul Analytics has 16 total employees.
-
What industry is Cannasoul Analytics in?
Cannasoul Analytics’s primary industry is Drug Discovery.
-
Is Cannasoul Analytics a private or public company?
Cannasoul Analytics is a Private company.
-
What is Cannasoul Analytics’s current revenue?
The current revenue for Cannasoul Analytics is .
-
How much funding has Cannasoul Analytics raised over time?
Cannasoul Analytics has raised $4M.
-
Who are Cannasoul Analytics’s investors?
InterCure and TAO Synergies have invested in Cannasoul Analytics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process